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CASE REPORT
A 75-year-old woman presented with severe hyperten-
sion, vague abdominal discomfort, and anemia 22 years
after aortorenal vein graft repair of a critical right renal
artery stenosis. She was referred to our center for further
care and admitted for acute blood pressure control.
Physical examination was remarkable for blood pressure of
200/100 mm Hg, mild abdominal tenderness in the right
upper abdomen with a pulsatile mass and palpable thrill,
and low-back tenderness but no flank pain or discol-
oration. Peripheral pulses were normal. Laboratory tests
demonstrated a serum creatinine level of 1.2 mg/dL,
hematocrit at 33%, and normal results from urinalysis.
Further workup included renal duplex ultrasound scan-
ning, which demonstrated a patent aortorenal vein graft
with aneurysmal degeneration to a 6-cm maximum diam-
eter. Abdominal computed tomography scan confirmed
the vein graft aneurysm and demonstrated laminated
mural thrombus (Fig 1). Selective angiography demon-
strated a saccular defect in the graft wall proximal to the
distal anastomosis (Fig 2).
After her blood pressure and cardiovascular status
were optimized, the patient was taken to the operating
suite for graft revision. During mobilization of the vein
graft aneurysm, a posterior wall defect was encountered
with a subacute, contained rupture proximal to the graft-
renal artery anastomosis, which was intact (Fig 3, A). The
aneurysm and the entire vein graft were resected, and the
thrombus was evacuated. A sleeve endarterectomy of the
aorta was performed, and a 6-mm polytetrafluoroethylene
graft was interposed between the aorta and the native
renal artery bifurcation (Fig 3, B). Intraoperative duplex
scanning showed no intraluminal flow defects, and the
postoperative course was uneventful. On discharge the
patient was normotensive while taking two antihyperten-
sive medications, and she had a serum creatinine level of
0.8 mg/dL. Serial duplex scanning graft surveillance was
initiated.
DISCUSSION
The saphenous vein is the most widely used con-
duit for arterial bypass graft procedures; more than
1 million vein grafts are placed in the coronary and
lower extremity vasculature in the United States
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each year.1 The vein is also the most common con-
duit used for renal artery reconstructions in adults.
In coronary and peripheral arterial beds, vein graft
failure is relatively common. Etiologies of failure
include acute thrombosis, early intimal hyperplasia,
and late atherosclerotic degeneration or progression
of underlying arterial disease. The leading cause of
graft failure in the coronary circulation is late graft
atherosclerotic degeneration following characteristic
“arterialization” and intimal thickening.2,3 Lower
extremity grafts have a higher incidence of early graft
failure due to intimal hyperplasia or valve sclerosis
and late failures due to progression of disease in the
native vasculature. In contrast, failure of vein grafts
in the renal arterial bed is uncommon. Causes most
commonly include stenosis and thrombosis.4,5
Dilation of renal grafts has been described, but
frank aneurysmal degeneration is unusual.4,5 To our
knowledge, rupture has only been reported once in
the previous literature6 with the current report con-
tributing the second case, underscoring the rarity of
this serious complication. Of the very large number
of aortocoronary vein grafts performed with exten-
sive late follow-up, only 31 true aneurysms have been
described in the literature with an average time to
presentation of 10.1 years.7,8 Lower extremity vein
grafts infrequently develop aneurysmal degeneration.
Although these cases are probably underreported, in
a recent review of the literature, 19 patients with 27
nonanastomotic aneurysms were described with an
average time to presentation of 7.8 years.9
In 1973, Stanley et al10 published the follow-up
of 100 aortorenal vein bypass grafts and warned of
the potential for aneurysmal degeneration of the
saphenous vein when used in the pediatric popula-
tion with renovascular hypertension. However, in a
review of complications of renal artery reconstruc-
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tion that required reoperation, aneurysm formation
was extremely rare, accounting for only three (1%)
of 278 aortorenal saphenous vein bypass grafts
requiring revision.4 The ages of the three patients
were 15, 18, and 49 years, and the average time to
revision was 28 months.4 In a separate review of 198
renal bypass grafts followed with angiography,
pathologic dilatation was noted in five saphenous
vein grafts, and all were in children. All were fol-
lowed by initial observation, and none required
reoperation because the initial enlargement stabi-
lized on serial follow-up examinations.11 From 1987
to 1997, we performed more than 780 renal artery
Fig 1. Abdominal computed tomography scan with intravenous contrast demonstrating right aor-
torenal vein graft aneurysm with laminated mural thrombus.
Fig 2. Selective arteriogram demonstrating aneurysmal
vein graft with saccular defect, which at operation was a
subacute contained rupture. Arrowheads denote the prox-
imal and distal anastomosis.
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reconstructions of which 290 were saphenous vein
grafts with a mean follow-up of 27 months. No vein
grafts have required revision for dilatation, and none
have ruptured.5
The cause of saphenous vein bypass graft enlarge-
ment with progression to aneurysm formation is
unknown. The distinct hemodynamic environment
of the renal bed with its low-resistance and high-
velocity blood flow may lead to enlargement of vein
grafts much as a radial-cephalic fistula matures. It has
been suggested that the disruption of the vasa vaso-
rum, especially in children in whom the adventitial
and medial plexuses are considered immature, con-
tributes to local ischemia and focal dilation.12 It has
been shown experimentally that vein grafts placed for
arterial bypass grafting reestablish their nonluminally
derived medial and adventitial blood supply within
48 to 72 hours.13 Poststenotic dilatation has also
been shown to lead to aneurysm formation in saphe-
nous vein grafts, which further highlights the impli-
cations of hemodynamic disturbances. Although the
true cause of these aneurysms remains to be eluci-
dated, their incidence remains extremely low. This
case represents only the second report of a ruptured
aortorenal saphenous vein bypass graft and is the first
in which a salvage bypass graft has been performed.6
In our view, the rarity of late complications
serves to highlight the durability of the saphenous
vein for use in renal revascularization. Long-term
duplex ultrasound scanning follow-up is recom-
mended to follow the reconstruction and perhaps
more important, to evaluate progression of subclin-
ical disease in the contralateral renal artery. Used for
aortorenal bypass grafting, the saphenous vein con-
tinues to be equal to or surpasses synthetic materials,
with respect to resistance to infection, ease of han-
dling for branch artery repair, and primary patency.
In our experience, the vein continues to be a favor-
able conduit for renal revascularization.
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